ERBB2 and breast carcinoma: Finally, the IUS group had the highest percentage of hormone receptor-positive and human epidermal growth factor receptor 2 (HER2)-negative breast cancers (IUS, 83%; wire, 74%; seed, 78%; p < 0.001).